23andMe Hires Schorno as CFO Before Relaunching DNA Health Test
This article is for subscribers only.
Silicon Valley genetic-testing company 23andMe Inc. said Monday it has hired Dean Schorno as chief financial officer and head of operations as the startup prepares to relaunch its health-testing product.
Schorno previously worked as CFO of closely held Adaptive Biotechnologies Corp. Before that, he spent nearly 15 years at Genomic Health Inc. in various executive roles including CFO, as the company grew and went public. Both Adaptive and Genomic Health offer genetic sequencing services, while 23andMe popularized the $99 “spit kit,” which scans people’s saliva for genetic information.